share_log

B. Riley Securities Initiates Coverage On Radiopharm Theranostics With Buy Rating, Announces Price Target of $15

Benzinga ·  Mar 12 09:36

B. Riley Securities analyst Yuan Zhi initiates coverage on Radiopharm Theranostics (NASDAQ:RADX) with a Buy rating and announces Price Target of $15.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 275

Recommended

Write a comment